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(LNA) antisense oligonucleotide diminishes HCV viremia in chimpanzees (17) . The antimiR-122 LNA molecule (known as Miravirsen) has since advanced to phase II human clinical trials for hepatitis C treatment, and appears to induce a potent antiviral effect in the absence of evident liver or cardiac toxicities (18) . miR-122 was also the first miRNA identified as a regulator of lipid metabolism (19) . In 2006, antisense oligonucleotide-mediated inhibition of miR-122 (ASO-miR-122) in mice reduced plasma cholesterol levels, decreased hepatic lipid synthesis, and enhanced hepatic fatty acid oxidation (19) . Moreover, the ASO-miR-122 was also able to reverse the effects of diet-induced obesity by reducing hepatic steatosis. Consistent with these findings, Miravirsen (anti-miR-122 LNA) has been shown to reduce plasma cholesterol levels in humans as well (18) . Recently, miR-122 was also demonstrated to be a critical regulator of hepatic circadian rhythm (20) , inflammation (21) , fibrosis (22) , and lipoprotein secretion (22) ; as such, it is a very important component of liver function and lipid homeostasis.
In the last few years, numerous studies have demonstrated that physiological and pathological changes in lipid metabolism are associated with altered hepatic and circulating miRNA profiles (5, 15, (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) . For example, Cheung et al found that the expression levels of 46 hepatic miRNAs are significantly altered in nonalcoholic steatohepatitis (NASH) compared to normolipidemic individuals (26) . Moreover, they demonstrated that many miRNAs, including miR-145, miR-27b, miR-30d, miR-34a, are more significantly altered in NASH than miR-122. Very recently, several of these by guest, on September 21, 2017 www.jlr.org Downloaded from miRNAs, such as miR-27b(28) and miR-34a (34) , and a growing number of others, including miR-125a, miR-33, miR-370, miR-378, miR-613, and miR-758, have been directly implicated in the regulation of lipid synthesis, transport, storage, and metabolism. Given these findings, which have been summarized in numerous recent review articles (35) (36) (37) (38) (39) (40) (41) , it is apparent that the activity of numerous miRNAs contributes to lipid homeostasis.
Genetic variation in the miRNA regulome and lipid-related disorders miRNA loci are transcribed predominantly by RNA Polymerase II(42), which yields primary transcripts (pri-miRNAs) that range from a few kilobases to a few hundred kilobases in length (43) . Pri-miRNAs harbor one or more hairpin-like secondary structures, termed precursor miRNAs (pre-miRNAs), which are cleaved and shuttled to the cytoplasm, where they are processed further into ~22bp double-stranded RNA duplexes (44) . One of the strands, referred to as the mature miRNA, is loaded onto the RNA Induced Silencing Complex (RISC). The miRNA guides and tethers the RISC to specific target sites within RNA molecules in order to regulate their stability and/or translation(3). The canonical pathway for miRNA biogenesis and targeting is shown in Figure 1 . The miRNA regulome is defined as the compendium of regulatory elements that either regulate miRNA expression (transcriptional control elements and premiRNAs) or are regulated by miRNA activity (RNA target sites). Genetic variation in the miRNA regulome can perturb miRNA expression and/or function, potentially contributing to a wide variety of lipid-related phenotypes (45) (46) (47) .
Genetic variation in miRNA transcriptional control elements
Transcriptional control elements can be classified as either proximal (i.e. promoter) or distal (i.e. long-range regulatory elements; LREs). Both classes of elements recruit transcriptional factor (TF) complexes that enhance or silence the expression of one or more genes (48) . Genetic mutations within these elements can alter the affinity for the binding of one or more TFs, and the resulting effect on full-length primary transcript of the gene. However, the primary transcripts of miRNAs are often too rapidly processed and degraded, which renders these traditional approaches less reliable for miRNA promoter identification (56) . In the last few years, several conceptual and technological advances in the field of epigenomics have allowed for the detection of miRNA promoter regions by analyzing chromatin structure (57, 58) . African Americans found significant population-specific interaction effects between dietary fatty acid intake and two SNPs (rs6008259 and rs3892755) in the 3'-UTR of peroxisome proliferator-activated receptor alpha (PPARA) (77) . PPARA is a lipidactivated TF that regulates the expression of many genes involved in hepatic lipid metabolism (78) . Although the authors did not explicitly discuss the possibility of a miRNA-related mechanistic link, a simple search of the TargetScan database (http://targetscan.org) suggests that rs3892755 is located within a predicted target site for miR-1204. Also, because association does not imply causation, it is entirely possible that one or both of rs6008259 and rs3892755 tags a haplotype block that contains the true functional variant(s). Therefore, in these types of cases, more detailed genetic and molecular experiments are necessary to determine whether the mechanism underlying the observed association is related to miRNA targeting. It remains unclear why the reduction of PLIN4, which is thought to be involved in the biogenesis of lipid droplets, would lead to increased adiposity (79) . Nonetheless, the authors' interesting findings strongly motivate further investigation into the function of PLIN4 and other closely related protein family members.
None of the aforementioned genetic associations, which were based on candidate gene studies, have yet been confirmed by unbiased genome-wide association studies (GWAS). In the past few years, GWAS have been conducted for hundreds of complex diseases and traits (80) . Several bioinformatic strategies have been developed to map GWAS-derived disease-associated variants, as well as SNPs in strong linkage disequilibrium (LD), onto predicted miRNA target sites (81) (82) (83) (84) (85) (86) . A very recent approach uncovered 87 such SNPs (84) . To date, only one of these, rs13702, has been validated by follow-up genetic and molecular studies (87) . Specifically,
Richardson et al performed a large-scale genetic association study in >25,000 individuals from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) and confirmed previous reports that the lipoprotein lipase (LPL) 3' UTR SNP rs13702 is associated with plasma lipid levels (87) . They also demonstrated that this association is significantly modulated by dietary intake of poly-unsaturated fatty acids (PUFAs), providing evidence for gene-by-diet interaction. To identify the molecular basis for the observed genetic association/interaction, they first performed an in silico by guest, on September 21, 2017 www.jlr.org Downloaded from screen for miRNA target sites, and predicted an allele-specific target site for a widely expressed miRNA, miR-410. They then determined, via in vitro reporter gene assays, that miR-410 targets only the rs13702 major allele, and that the rs13702 minor allele abrogates miR-410 mediated repression of LPL (87) . This seminal study represents the best evidence to date for a miRNA-mediated mechanism underlying a GWAS-derived complex trait genetic association. Furthermore, they reported that 21 of these miR-eQTLs were previously associated with several complex traits/diseases in GWAS (88) . One of these is the SNP rs3846662, which is strongly associated with the LCL expression levels of miR-221 (p = 1.1 x 10 -7 )
and miR-222 (p = 3.5 x 10 -8 ), and also significantly associated with total plasma cholesterol (p = 3.0 x 10 -19 ). In support of this result, another recent study found that miR-221 and miR-222 are among the most significantly down-regulated hepatic miRNAs in baboons with high LDL-C that were fed a high-cholesterol/high-fat diet (27) .
These interesting findings highlight the utility of systems genetics approaches to generate miRNA-related mechanistic hypotheses for genetic loci associated with lipidrelated traits/disorders. Moreover, the power to detect miR-eQTLs associated with disease will only increase as studies such as the one from Gamazon et al are performed in larger cohorts across broader sets of cell types.
Summary
• miRNA networks regulate hepatic and systemic lipid homeostasis.
• Although there are only a few examples to date, there is growing evidence that natural genetic variation in the miRNA regulome, including transcriptional control elements and target sites, can directly influence metabolism and lipidemic status.
• A few recent studies indicate that genetic variation in miRNA networks may underlie "gene by diet" interactions that are of direct relevance to public health.
• Systems genetics offers an unprecedented view of the miRNA-related genetic landscape of inter-individual variability in lipid phenotypes. 
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